Company news
OraSure Technologies, Inc. news in 2022
OraSure Technologies, Inc.'s news releases, calls and decks from 2022, newest first.
OraSure Technologies Continues its Dedication to Ending the HIV Epidemic
November 30, 2022
OraSure Technologies to Present at Stephens Annual Investment Conference
November 13, 2022
OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year
November 7, 2022
OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)
November 2, 2022
InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store
November 1, 2022
2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5: 00 p.m. ET
October 31, 2022
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
September 27, 2022
OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention
September 19, 2022
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health
September 13, 2022
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year
August 8, 2022
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5: 00 p.m. ET
August 1, 2022
OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack
July 27, 2022
OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA
July 13, 2022
OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 7, 2022
InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing
May 24, 2022
Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure
May 22, 2022
InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants
May 16, 2022
OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue
May 9, 2022
OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5: 00 p.m. ET
May 2, 2022
OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples
April 6, 2022
OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples
March 30, 2022
OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role
March 21, 2022
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
February 22, 2022
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5: 00 p.m. ET
February 15, 2022
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App
January 30, 2022
OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe
January 24, 2022
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
January 12, 2022
OraSure Technologies Announces Actions to Enhance Stockholder Value
January 4, 2022
Decks in 2022
- Q2 2022 Earnings Presentation
Earnings · 15 slides · Aug 9, 2022
- Q1 2022 Earnings Presentation
Earnings · 14 slides · May 10, 2022
- Q4 2021 Earnings Presentation
Earnings · 15 slides · Feb 23, 2022